Doubling of testicular cancer incidence rate over the last 20 years in southern France

被引:0
|
作者
Marie Walschaerts
Eric Huyghe
Audrey Muller
Jean-Marc Bachaud
Louis Bujan
Patrick Thonneau
机构
[1] University Paul Sabatier-Toulouse III,Human Fertility Research Group (EA 3694)
[2] INSERM,Human Fertility Research Group (EA 3694)
[3] Claudius Regaud Regional Cancer Institute,undefined
[4] Hôpital Paule de Viguier,undefined
来源
Cancer Causes & Control | 2008年 / 19卷
关键词
Testicular cancer; Incidence; Birth cohort effect; Public health;
D O I
暂无
中图分类号
学科分类号
摘要
In recent decades, testicular cancer incidence has considerably increased in a majority of industrialized countries. In France, short reports suggested that the testicular cancer incidence rate has also risen, especially in north-eastern regions. In Europe, geographical variation of incidence rates has been observed in Baltic countries and a clear birth cohort effect has been revealed. This study aimed to assess temporal trends in testicular cancer incidence in southern France. We examined incidence rates over a 20-year time period in a series of 506 consecutive cases of testicular cancer recorded from 1980 to 1999 in the Midi-Pyrenees region of France. Age, calendar period, and birth cohort effects were examined simultaneously using Poisson regression models. Our analysis found a significant rise in the overall incidence rate of testicular germ cell tumors from 1.27 to 3.04 per 100,000 between 1980–1984 and 1995–1999, an annual increase of 5.70%. These results, the first obtained in a large series in southern Europe, show a twofold increase in incidence rate of testicular cancer in the Midi-Pyrenees region, which is very similar to that observed in all European countries, more or less doubling in the last 20 years. Interestingly, this major jump and the apparent testicular cancer gradient between northern and southern Europe suggest considerable geographical heterogeneity in incidence, but low geographical variation in temporal trends.
引用
收藏
页码:155 / 161
页数:6
相关论文
共 50 条
  • [21] Milestones in gynecological oncology over the last 20 years
    Pfleiderer, A
    ONKOLOGIE, 2000, 23 (06): : 615 - 618
  • [22] THE TREATMENT OF TETANUS - EXPERIENCE OVER THE LAST 20 YEARS
    SCHRODER, J
    ERICHSEN, H
    HUCKSTADT, A
    SCHRODER, D
    ANASTHESIOLOGIE & INTENSIVMEDIZIN, 1993, 34 (10): : 321 - 324
  • [23] Hospital pharmacy in Luxembourg over the last 20 years
    Engelhardt, Patrick
    EJHP PRACTICE, 2010, 16 (03): : 44 - 45
  • [24] Implied Cost of Capital over the Last 20 Years
    Kitagawa, Norio
    Gotoh, Masatoshi
    JAPANESE ACCOUNTING REVIEW, 2011, 1 : 71 - 104
  • [25] Progress in clinical pharmacology over the last 20 years
    Eichelbaum, M
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 55 (05) : 458 - 459
  • [26] Trisomy 18 Trends Over the Last 20 Years
    Fick, Tyler A.
    Tejtel, S. Kristen Sexson
    PEDIATRICS, 2021, 147 (03)
  • [27] Trisomy 18 Trends over the Last 20 Years
    Fick, Tyler A.
    Tejtel, S. Kristen Sexson
    JOURNAL OF PEDIATRICS, 2021, 239 : 206 - +
  • [28] Acceptance of WHO/MDT over the last 20 years
    Lechat, MF
    INTERNATIONAL JOURNAL OF LEPROSY AND OTHER MYCOBACTERIAL DISEASES, 2001, 69 (03) : 241 - 246
  • [29] TRENDS IN INCIDENCE FOR GESTATIONAL TROPHOBLASTIC DISEASE OVER THE LAST 20 YEARS IN A POPULATION-BASED STUDY
    Eysbouts, Y. K.
    Bulten, J.
    Ottevanger, P. B.
    Thomas, C. M. G.
    Ten Kate-Booij, M. J.
    van Herwaarden, A. E.
    Siebers, A. G.
    Sweep, F. C. G. J.
    Massuger, L. F. A. G.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (09) : 90 - 90
  • [30] Trends in incidence for gestational trophoblastic disease over the last 20 years in a population-based study
    Eysbouts, Y. K.
    Bulten, J.
    Ottevanger, P. B.
    Thomas, C. M. G.
    ten Kate-Booij, M. J.
    van Herwaarden, A. E.
    Siebers, A. G.
    Sweep, F. C. G. J.
    Massuger, L. F. A. G.
    GYNECOLOGIC ONCOLOGY, 2016, 140 (01) : 70 - 75